These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 17536001)

  • 21. Rapid correction of bone mass after parathyroidectomy in an adolescent with primary hyperparathyroidism.
    Vanstone MB; Udelsman RD; Cheng DW; Carpenter TO
    J Clin Endocrinol Metab; 2011 Feb; 96(2):E347-50. PubMed ID: 21106715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parathyroidectomy for Normocalcemic Primary Hyperparathyroidism is Associated with Improved Bone Mineral Density Regardless of Postoperative Parathyroid Hormone Levels.
    Lui MS; Clemente-Gutierrez U; Vodopivec DM; Chang SL; Shirali AS; Huang BL; Chiang YJ; Fisher SB; Grubbs EG; Guise TA; Graham PH; Perrier ND
    World J Surg; 2023 Feb; 47(2):363-370. PubMed ID: 36195677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Primary hyperparathyroidism - new clinical forms of the disease].
    Zajíčková K
    Vnitr Lek; 2017; 63(9):604-608. PubMed ID: 29120658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Surgical indications of primary hyperparathyroidism].
    Tominaga Y
    Clin Calcium; 2005 Dec; 15(12):79-84. PubMed ID: 16322678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical profile of primary hyperparathyroidism from western India: a single center experience.
    Gopal RA; Acharya SV; Bandgar T; Menon PS; Dalvi AN; Shah NS
    J Postgrad Med; 2010; 56(2):79-84. PubMed ID: 20622385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FCH-PET/CT in Primary Hyperparathyroidism With Discordant/Negative MIBI Scintigraphy and Ultrasonography.
    Koumakis E; Gauthé M; Martinino A; Sindayigaya R; Delbot T; Wartski M; Clerc J; Roux C; Borderie D; Cochand-Priollet B; Cormier C; Gaujoux S
    J Clin Endocrinol Metab; 2023 Jul; 108(8):1958-1967. PubMed ID: 36750257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgical management of normocalcemic primary hyperparathyroidism.
    Wade TJ; Yen TW; Amin AL; Wang TS
    World J Surg; 2012 Apr; 36(4):761-6. PubMed ID: 22286968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial.
    Khan AA; Bilezikian JP; Kung AW; Ahmed MM; Dubois SJ; Ho AY; Schussheim D; Rubin MR; Shaikh AM; Silverberg SJ; Standish TI; Syed Z; Syed ZA
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3319-25. PubMed ID: 15240609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative utility of preoperative imaging in normocalcemic versus hypercalcemic primary hyperparathyroidism.
    Montgomery KB; Gillis A; Ramonell KM; Fazendin JM; Lindeman B; Chen H
    Am J Surg; 2023 Feb; 225(2):293-297. PubMed ID: 36175194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone densitometry: patients with asymptomatic primary hyperparathyroidism part I. Technical report.
    Erlichman M; Holohan TV
    Health Technol Assess (Rockv); 1995 Dec; (6):1-30. PubMed ID: 8938232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is intraoperative parathyroid hormone assay mandatory for the success of targeted parathyroidectomy?
    Gil-Cárdenas A; Gamino R; Reza A; Pantoja JP; Herrera MF
    J Am Coll Surg; 2007 Feb; 204(2):286-90. PubMed ID: 17254933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of kidney stones and vertebral fractures in primary hyperparathyroidism using imaging technology.
    Cipriani C; Biamonte F; Costa AG; Zhang C; Biondi P; Diacinti D; Pepe J; Piemonte S; Scillitani A; Minisola S; Bilezikian JP
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1309-15. PubMed ID: 25646791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Normocalcemic Hyperparathyroidism: Study of its Prevalence and Natural History.
    Schini M; Jacques RM; Oakes E; Peel NFA; Walsh JS; Eastell R
    J Clin Endocrinol Metab; 2020 Apr; 105(4):e1171-86. PubMed ID: 32072184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcimimetics versus parathyroidectomy for treatment of primary hyperparathyroidism: retrospective chart analysis of a prospective database.
    Keutgen XM; Buitrago D; Filicori F; Kundel A; Elemento O; Fahey TJ; Zarnegar R
    Ann Surg; 2012 May; 255(5):981-5. PubMed ID: 22470074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial.
    Ambrogini E; Cetani F; Cianferotti L; Vignali E; Banti C; Viccica G; Oppo A; Miccoli P; Berti P; Bilezikian JP; Pinchera A; Marcocci C
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3114-21. PubMed ID: 17535997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Normocalcemic, subclinical, asymptomatic primary hyperparathyroidism in patients with goiter or papillary thyroid cancer--preliminary report. Normocalcemic primary hyperparathyroidism and thyroid pathology.
    Niedźwiecki S; Kuzdak K; Kaczka K; Pomorski L
    Wiad Lek; 2007; 60(5-6):228-30. PubMed ID: 17966885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. "Incipient" primary hyperparathyroidism: a "forme fruste" of an old disease.
    Silverberg SJ; Bilezikian JP
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5348-52. PubMed ID: 14602772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Skeletal effects of interventions in mild primary hyperparathyroidism: a meta-analysis.
    Sankaran S; Gamble G; Bolland M; Reid IR; Grey A
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1653-62. PubMed ID: 20130069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteoporosis in multiple endocrine neoplasia type 1: severity, clinical significance, relationship to primary hyperparathyroidism, and response to parathyroidectomy.
    Burgess JR; David R; Greenaway TM; Parameswaran V; Shepherd JJ
    Arch Surg; 1999 Oct; 134(10):1119-23. PubMed ID: 10522858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of obesity on the presentation of primary hyperparathyroidism.
    Tran H; Grange JS; Adams-Huet B; Nwariaku FE; Rabaglia JL; Woodruff SL; Holt SA; Maalouf NM
    J Clin Endocrinol Metab; 2014 Jul; 99(7):2359-64. PubMed ID: 24684459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.